Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: knee

What Physical & Occupational Therapists Wish Rheumatologists Knew

Linda Childers  |  June 17, 2019

Kim Steinbarger, PT, MHS, knows how physical and occupational therapy can make a difference for patients with rheumatic diseases. Ms. Steinbarger was just two years into her career as a physical therapist (PT) when she was diagnosed with rheumatoid arthritis (RA) in 1991. “I’ve seen how regular exercise serves as an important tool in managing…

Filed under:ConditionsPractice Support Tagged with:Association of Rheumatology Professionals (ARP)Occupational TherapyPhysical Therapy

Predictors of RA Flare After Total Joint Arthroplasty

Carina Stanton  |  May 20, 2019

At the time of total joint arthroplasty, RA disease activity has been shown to better predict postoperative flare than medication management…

Filed under:ConditionsRheumatoid Arthritis Tagged with:flarehipJoint SurgerykneeRA flaresRheumatoid Arthritis (RA)total hip arthroplastytotal knee arthroplasty

What Pharmacists Want Rheumatologists to Know

Linda Childers  |  May 18, 2019

Involving pharmacists in the management of chronic diseases benefits patients, says Wendy Ramey, BSPharm, RPh, CSP, a clinical pharmacy specialist in rheumatology at the University of Kentucky, Lexington. She knows this personally. As someone with rheumatoid arthritis (RA), Ms. Ramey knows pharmacists can play an important role in patient education and encouraging adherence to medications….

Filed under:Patient PerspectivePractice Support Tagged with:adherenceAssociation of Rheumatology Professionals (ARP)pharmacistprior authorizationself-injectionvaccination

Psoriatic Arthritis: A Look Back at Moll & Wright’s Landmark 1973 Paper

Ruth Jessen Hickman, MD  |  May 17, 2019

Psoriatic arthritis came to be viewed as a distinct disease entity with specific clinical features, genetics and pathophysiology only gradually. One important historic development in this transition was a 1973 paper written by a pair of researchers out of Leeds, England: John M. Moll, BSc, DM, and Verna Wright, MD, FRCP.1 Here we discuss the…

Filed under:ConditionsPsoriatic Arthritis Tagged with:Classification CriteriaClassification of Psoriatic Arthritis (CASPAR)criteriaLost & FoundMoll and Wright criteriaPsoriatic Arthritis

MicroOne / shutterstock.com

Rheumatology Drugs at a Glance, Part 2: Psoriasis

Mary Choy, PharmD, BCGP, FASHP  |  May 17, 2019

Over the past few years, bio­similars and other new drugs have been introduced to treat rheumatic illnesses. Some of the conditions we treat have numerous drug option; others have few or only off-label options. This series, “Rheumatology Drugs at a Glance,” provides streamlined information on the administration of biologic, biosimilar and other medications used to…

Filed under:ConditionsDrug Updates Tagged with:adalimumabapremilastbrodalumabCertolizumab Pegoletanerceptguselkumabguttate psoriasisinfliximabinverse psoriasisixekizumabPsoriatic Arthritispsoriatic erythrodermapustular psoriasisRheumatic Drugs at a Glancesecukinumabtildrakizumabustekinumabvulgar psoriasis

Coding Corner Question: How to Bill a Rituximab Infusion Visit?

From the College  |  April 16, 2019

A 66-year-old female patient returns for a second infusion of rituximab for her diagnosis of rheumatoid arthritis in multiple sites. She is rheumatoid factor positive. She says the pain in her knees, elbows and neck has slightly improved. She rates the severity of her pain at a 7 on a 10-point scale, which is an…

Filed under:Billing/CodingFrom the CollegeRheumatoid Arthritis Tagged with:Infusionrituximab

Tips for Interdisciplinary Pain Management in Older Patients

Susan Bernstein  |  April 15, 2019

CHICAGO—Rheumatology healthcare providers should embrace collaborative approaches to manage chronic musculoskeletal pain in older adult patients, including models of care that involve multiple providers, patients and their caregivers. That was the message delivered by two speakers in the Interdisciplinary Management of Chronic Musculo­skeletal Pain in Older Adults session at the 2018 ACR/ARHP Annual Meeting. “As…

Filed under:AnalgesicsConditions Tagged with:2018 ACR/ARHP Annual MeetingbiopsychosocialcollaborationExerciseinterdisciplinaryPain Managementstepped care

New Tools for Myositis Diagnosis, Classification & Management

Susan Bernstein  |  April 15, 2019

CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

Filed under:ConditionsOther Rheumatic Conditions Tagged with:2018 ACR/ARHP Annual Meetingfibrosing myopathyidiopathic inflammatory myopathiesinclusion body myositis (IBM)overlap myositis

At Vasculitis Conference, Patients Share Hope, Humor & Hardships

Bryn Nelson, PhD  |  April 15, 2019

SEATTLE—At the first regional vasculitis patient conference ever held in the Pacific Northwest, a panoramic view of Mt. Rainier on a clear January morning set the tone for a day of optimistic talks about recent successes against the various forms of blood vessel inflammation. One attendee at the Jan. 12 conference, sponsored by the Vasculitis…

Filed under:Patient PerspectiveVasculitis Tagged with:vasculitis research

Insights on the Diagnosis & Treatment of Low Back & Hip Pain

Susan Bernstein  |  March 19, 2019

CHICAGO—Two experts presented insights on the diagnosis and treatment of low back and hip pain, including a refresher course on the mechanical structures involved, in Anatomy in a Day: Demystifying Low Back Pain and Lateral Hip Pain: New Patho-Anatomical Perspectives, a session at the 2018 ACR/ARHP Annual Meeting. Low Back Pain Avoid using such terms…

Filed under:ConditionsMeeting Reports Tagged with:2018 ACR/ARHP Annual Meetinghip painlow back painUltrasound

  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 78
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences